Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
JCEM Publishes Data from OXiGENE-sponsored Preclinical Study of Combretastatin A4 phosphate / CA4P Triple-Drug Combinations in Anaplastic Thyroid Cancer Triple-drug combination therapy shows...
-
OXiGENE Appoints Patricia Walicke, M.D., Ph.D. as Chief Medical Officer Drug Development Veteran to Oversee Clinical Development WALTHAM, Mass.--(BUSINESS WIRE)--July 31, 2007--Regulatory...
-
OXiGENE Reports Second Quarter Financial Results and Provides Progress Update WALTHAM, Mass.--(BUSINESS WIRE)--July 25, 2007--Regulatory News: OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a...
-
OXiGENE Schedules Second Quarter 2007 Earnings Conference Call Live Internet Webcast to be Available at www.oxigene.com WALTHAM, Mass.--(BUSINESS WIRE)--July 16, 2007--Regulatory News: ...
-
OXiGENE Schedules Second Quarter 2007 Earnings Conference Call Live Internet Webcast to be Available at www.oxigene.com WALTHAM, Mass.--(BUSINESS WIRE)--July 18, 2007--Regulatory News: ...
-
OXiGENE Begins Pivotal Registration Study for ZYBRESTAT(TM) in Anaplastic Thyroid Cancer WALTHAM, Mass.--(BUSINESS WIRE)--July 9, 2007--Regulatory News: OXiGENE, Inc. (NASDAQ: OXGN, XSSE:...
-
OXiGENE Adds Two New Directors to Its Board WALTHAM, Mass.--(BUSINESS WIRE)--June 27, 2007--Regulatory News: OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a clinical-stage biopharmaceutical company...
-
OXiGENE Abstracts Published in ASCO Program -- Phase II Combretastatin A4 Phosphate / CA4P study with paclitaxel and carboplatin shows safety, anti-tumor activity, and reduced blood flow --...
-
OXiGENE Reaches Agreement with FDA on Special Protocol Assessment for ZYBRESTAT(TM) (CA4P) Phase II/III Pivotal Trial in Anaplastic Thyroid Cancer Phase II/III Pivotal Trial Expected to Begin...
-
OXiGENE Announces a Poster Presentation Highlighting Results from its Study of ZYBRETSTAT™ CA4P in Myopic Macular Degeneration (Study MMD-213) at the 47th Annual Meeting of the Association of Research...